Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake.
Loza E, Carmona L, Woolf A, Fautrel B, Courvoisier DS, Verstappen S, Aarrestad Provan S, Boonen A, Vliet Vlieland T, Marchiori F, Jasinski T, Van der Elst K, Ndosi M, Dziedzic K, Carrasco JM. Loza E, et al. Among authors: fautrel b. Ann Rheum Dis. 2022 Oct;81(10):1344-1347. doi: 10.1136/ard-2022-223016. Epub 2022 Aug 12. Ann Rheum Dis. 2022. PMID: 35961760
Cost of illness studies in rheumatic diseases.
Fautrel B, Guillemin F. Fautrel B, et al. Curr Opin Rheumatol. 2002 Mar;14(2):121-6. doi: 10.1097/00002281-200203000-00008. Curr Opin Rheumatol. 2002. PMID: 11845016 Review.
Economic consequences and potential benefits.
Fautrel B, Verstappen SM, Boonen A. Fautrel B, et al. Best Pract Res Clin Rheumatol. 2011 Aug;25(4):607-24. doi: 10.1016/j.berh.2011.10.001. Best Pract Res Clin Rheumatol. 2011. PMID: 22137927 Review.
Inequities in access to biologic and synthetic DMARDs across 46 European countries.
Putrik P, Ramiro S, Kvien TK, Sokka T, Pavlova M, Uhlig T, Boonen A; Working Group ‘Equity in access to treatment of rheumatoid arthritis in Europe’. Putrik P, et al. Ann Rheum Dis. 2014 Jan;73(1):198-206. doi: 10.1136/annrheumdis-2012-202603. Epub 2013 Mar 6. Ann Rheum Dis. 2014. PMID: 23467636
Worker productivity outcome measures: OMERACT filter evidence and agenda for future research.
Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Petersson IF, Purcaru O, Bombardier C, Tugwell PS, Beaton DE. Tang K, et al. Among authors: fautrel b. J Rheumatol. 2014 Jan;41(1):165-76. doi: 10.3899/jrheum.130815. Epub 2013 Oct 15. J Rheumatol. 2014. PMID: 24128774
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, Bosworth A, Gignac MA, Leong A, Purcaru O, Leggett S, Hofstetter C, Peterson IF, Tang K, Fautrel B, Bombardier C, Tugwell PS. Beaton DE, et al. Among authors: fautrel b. J Rheumatol. 2016 Jan;43(1):214-22. doi: 10.3899/jrheum.141077. Epub 2015 Sep 1. J Rheumatol. 2016. PMID: 26329339 Review.
Test-retest Reliability and Correlations of 5 Global Measures Addressing At-work Productivity Loss in Patients with Rheumatic Diseases.
Leggett S, van der Zee-Neuen A, Boonen A, Beaton DE, Bojinca M, Bosworth A, Dadoun S, Fautrel B, Hagel S, Hofstetter C, Lacaille D, Linton D, Mihai C, Petersson IF, Rogers P, Sergeant JC, Sciré C, Verstappen SM; At-work Productivity Global Measure Working Group. Leggett S, et al. Among authors: fautrel b. J Rheumatol. 2016 Feb;43(2):433-9. doi: 10.3899/jrheum.141605. Epub 2015 Dec 1. J Rheumatol. 2016. PMID: 26628608
406 results